The World Health Organization convenes an emergency meeting Monday to help determine its response to the Zika virus.
Developing a vaccine is no small feat. First, you need a lot of cash, said Dr. Ken Kaitin at the Tufts Center for the Study of Drug Development.
“It could take close to $1 billion to bring one successful compound to market,” he said.
Then, Kaitin said, given that pregnant women are at risk, that complicates the process for drug makers.
“In anything that’s dealing with pregnancy or children for that matter, you have an added obstacle because you don’t want to create a bigger problem then you are trying to cure,” he said.
A few of the biggest drug companies in the world are exploring vaccine development, including GlaxoSmithKline and Sanofi.
The Zika virus could infect some 4 million people in the Americas, and that’s why Sanofi’s Dr. Paul Beninger hopes U.S. health officials round up all the pharmaceutical executives and put the screws to them.
“Putting the finger to every person in the room and say I need your help to do this. And I think people respond to that. It’s when they aren’t identified it doesn’t happen,” he said.
Beninger said as we saw with Ebola, the capacity to develop a vaccine is there. It’s just a question of unlocking it.
If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air. But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.
Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.
When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.